Below are the most recent publications written about "Multiple Myeloma" by people in Profiles.
-
Mailankody S, Mitra S, Herrera K, Ziccheddu B, Cadzin B, Eren OC, Farzana T, Ullah T, Landa J, Derkach A, Chaudhari J, McAvoy DP, Hosszu K, Shah GL, Landau H, Maura F, Dogan A, Giralt S, Wang X, Sadelain M, Smith EL, Brentjens RJ, Leslie C, Usmani SZ, Perica K. Concurrent administration of BCMA and GPRC5D CAR T cells for advanced multiple myeloma. Blood. 2026 Oct 22; 148(17):2121-2131.
-
Merz M, Souto Filho JT, Voorhees PM, Einsele H, Schjesvold F, Cliff ERS, Mateos MV, Hungria V, Cohen YC, de Larrea CF, Beksac M, Landgren O, Usmani SZ, Costa LJ, Gagelmann N. T-cell-redirecting therapies in early relapsed multiple myeloma: a systematic review and network meta-analysis. J Hematol Oncol. 2026 10 07; 19(1).
-
Mian H, Faisal MS, Chen T, Brazauskas R, Oloyede T, Ahmed N, Afrough A, Anderson LD, Banerjee R, Berdeja J, Bidikian A, Devos J, Dhakal B, Dias A, Dima D, Efebera YA, Gowda L, Hansen DK, Hashmi H, Landau HJ, Lekakis L, Mirza AS, Narra R, Patel K, Rosko AE, Schroeder M, Sidana S, Usmani S, Pasquini MC, Nishihori T, Akhtar OS, Mohan M. Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis. Cancer. 2026 Oct 01; 132(19):e70614.
-
Miller KC, Fei T, Faustino Ramos RJ, Castro F, Gradissimo A, Block T, Hamadeh I, Maclachlan KH, Hultcrantz ML, Hassoun H, Mailankody S, Rajeeve S, Maura F, Merz M, Hashmi H, Firestone R, Jurgens E, Shah GL, Scordo M, Landau HJ, Giralt SA, Korde N, Pianko MJ, Usmani SZ, Peled JU, Shah UA, Lesokhin AM. Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool. Clin Cancer Res. 2026 Oct 01; 32(19):4474-4488.
-
Herrera K, Mitra S, Sun Y, Lucero K, Singh KA, Chen K, Takizawa M, Shah GL, Giralt S, Park JH, Usmani SZ, Chaligne R, de Stanchina E, Mailankody S, Leslie CS, Perica K. The EF1? promoter of cilta-cel drives a highly effective GZMK+ transcriptional program. Nat Commun. 2026 09 19; 17(1).
-
Maclachlan KH, Papadimitriou M, Blaney P, Baughn LB, Shekarkhand T, Poos AM, Ziccheddu B, Tang H, Yan H, Diamond B, Zhang Y, Cimera R, Dogan A, Gagler D, Boyle E, Hultcrantz M, Mailankody S, Hassoun H, Shah UA, Tan C, Brown EE, Winterkorn L, Chu T, Steinsnyder Z, Vaksman Z, Davies FE, Korde N, Landgren O, Raab MS, Lesokhin AM, Robine N, Weinhold N, Usmani SZ, Maura F, Morgan GJ. Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry. Blood Cancer Discov. 2026 Sep 03; 7(5):742-758.
-
Zweegman S, Facon T, Hungria V, Bahlis NJ, Venner CP, Braunstein M, Pour L, Marti J, Basu S, Cohen YC, Matsumoto M, Suzuki K, Hulin C, Grosicki S, Legiec W, Beksac M, Maiolino A, Takamatsu H, Perrot A, Turgut M, Liu W, Wang J, van Brummelen E, Krevvata M, Lopez-Masi L, Carey J, Borgsten F, Rowe M, Carson R, Usmani SZ. Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS. Blood Adv. 2026 08 25; 10(16):5594-5606.
-
Facon T, Kumar SK, Orlowski RZ, Bahlis N, Moreau P, Goldschmidt H, Basu S, Hulin C, Zweegman S, Weisel K, Perrot A, Jacquet C, Raje N, Manier S, Chari A, Hansson M, Mohty M, Delforge M, Plesner T, Cook G, Leleu X, Quach H, Venner CP, Tiab M, Macro M, Frenzel L, Wang G, Pei H, Bolyard K, Carson R, Borgsten F, Usmani SZ. Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis. Leukemia. 2026 Nov; 40(11):2530-2539.
-
Jurgens EM, Mitra S, Herrera K, Nemirovsky D, Bready B, Derkach A, Hosszu K, McAvoy D, Firestone RS, Rajeeve S, Lesokhin AM, Korde N, Tan CR, Hashmi H, Hassoun H, Maclachlan K, Shah UA, Hultcrantz M, Merz M, Maura F, Giralt SA, Shah GL, Landau HJ, Scordo M, Kotchetkov IS, Santomasso BD, Park J, Leslie CS, Usmani SZ, Perica K, Mailankody S. Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma. Sci Transl Med. 2026 Jul 29; 18(860):eaed0039.
-
Kastritis E, Kumar SK, Rajkumar VS, Chng WJ, Costa L, Engelhardt M, Gonsalves W, Hungria V, Hillengass J, Jevremovic D, Katodritou E, Kristinsson SY, Lonial S, Ludwig H, McCarthy P, Mai E, Manier S, Martin T, Mateos MV, Mian H, Mikhael J, Moreau P, Munshi NC, Paiva B, Pawlyn C, Rasche L, Richter J, San Miguel J, Sborov DW, Usmani SZ, Dimopoulos MA, Zamagni E. International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas. J Clin Oncol. 2026 09; 44(25):2447-2459.